Onkure Therapeutics (OKUR) traded down -1.79 % during a 24 hours period ending at 10:13 PM Central Europe on Tuesday 27th. One Onkure Therapeutics stock can currently be bought for about USD 2.59 on popular exchanges. Current supply of Onkure Therapeutics stocks is 40.7 mn. Onkure Therapeutics has a current market capitalization of USD 100.4 mn and approximately USD 638.8 k worth of Onkure Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Onkure Therapeutics has traded -10.33 % down. Simple moving average of last 200 days is at USD 3.62. The highest price of past 52 weeks was recorded at USD 5.38 on 05/01/2026. 52 weeks low was at USD 2.01 on 10/16/2026.

Here is how related stocks have performed in the past 24 hours:

  • Wisesat Space (SAIQ) traded up 9.97 % and now trades at USD 7.52. Wisesat Space has a market capitalisation of USD 118.7 mn. WISeSat.Space Holdings Corp. announced on 26 October 2026 a binding letter of intent with its sister company SEALSQ Corp. The agreement outlines a planned acquisition of satellite capacity and related operational services from WISeSat.Space’s twelve‑satellite constellation, alongside mission‑control, ground‑segment and support services. The transaction is intended to establish the initial orbital and terrestrial infrastructure for the Quantum Spatial Orbital Cloud (QSOC), a platform that will combine satellite connectivity with SEALSQ’s post‑quantum security and identity technologies. WISeSat.Space will continue to procure and operate the satellites, while SEALSQ will develop and commercialise QSOC’s security‑service layer. The deal follows the company’s recent Nasdaq listing and a $10 million private equity investment by SEALSQ, positioning WISeSat.Space to monetize its satellite capacity and expand its secure space‑infrastructure offering.

  • Gct Semiconductor (GCTS) traded down -4.65 % and now trades at USD 1.27. Gct Semiconductor has a market capitalisation of USD 118.6 mn.

  • Retension (RTSN) traded down -6.62 % and now trades at USD 13.52. Current market capitalisation for Retension is USD 118.2 mn.

  • Anavex Life Sciences (AVXL) traded down -3.76 % and now trades at USD 1.31. Anavex Life Sciences has a market capitalisation of USD 120.5 mn.

  • Owlet (OWLT) traded down -1.71 % and now trades at USD 4.19. Current market capitalisation for Owlet is USD 119.3 mn.

About Onkure Therapeutics

Reneo Pharmaceuticals, Inc. is a pharmaceutical company operating in the health care sector with its base in Irvine, United States. The company specializes in the development of therapies for patients suffering from rare genetic diseases, particularly mitochondrial diseases with significant unmet medical needs. Reneo serves patients in the United States and the United Kingdom and can be accessed online through their webpage at www.reneopharma.com . The company’s stock is traded on the Nasdaq stock exchange.